Magnetron, a high-powered vacuum tube, is an essential component for Medical LINAC (Linear Accelerator), which are widely used for external radiation treatment of cancer patients. CSIR-CEERI, Pilani, had recently designed and developed 2.6 MW S-band tunable pulsed Magnetron, which was successfully tested and used as a microwave source, to generate the required X-ray dose using a LINAC system for cancer treatment.
On 14 July 2020, the technology know-how for S-band Magneton was transferred to M/s Panacea Pvt. Ltd, Bangalore, known for developing advanced radiotherapy systems for cancer treatment.
On the occasion, Dr R.K. Sharma, Area Coordinator of Microwave Devices Area, Dr Shivendra Maurya, Principal Scientist and Head-Magnetron Activity, presented the technical details of the device. Amongst other participants Dr Shekar C. Mande, Director-General, CSIR; Dr P.C. Panchariya, Director, CSIR-CEERI; Dr D.K. Aswal, Director, CSIR-NPL; Dr A.K. Mohanty, Dr Archana Sharma and Dr Sri Krishna Gupta, from BARC, Mumbai, Dr P.K. Khanna, Chief Scientist, CSIR-CEERI & Dr J.L. Raheja, Head PMBD, CSIR-CEERI, also witnessed the presentation and know-how transfer ceremony through online platform.
The DG, CSIR, congratulated CSIR-CEERI on its achievement and said that the transfer of know-how to Panacea Pvt. Ltd would facilitate the dissipation of the benefits of the Magnetron technology to common people. He further said that the transfer of the Magnetron technology know-how by CSIR- CEERI is, in fact, an effort towards realising Atmanirbhar Bharat, as the imported Magnetrons will now be replaced by the Indian made Magnetrons.
Later, Dr P. C. Panchariya, during his address said that the Microwave Devices Area of the institute has been in existence since CSIR-CEERI’s inception. He said that, with this know-how transfer, the S-Band Magnetron Technology, designed and developed by CSIR-CEERI, would be able to serve the society, and would also bring down the import requirement. He added that occasions such as these mark the accomplishment of CSIR-CEERI’s efforts towards Make in India and Atmanirbhar Bharat Abhiyan.
Earlier, Dr D.K. Aswal, Director CSIR-NPL, who until recently, held the additional charge of Director CSIR-CEERI, while addressing the participants, pointed out that Magnetron Technology apart from medical applications is also required by industries and for strategic applications. He stressed on the fact that the requirement for Magnetron is too high and is estimated to cover a market of almost a trillion US dollar, which offers an opportunity to those working in this area. The representative from Panacea Pvt Ltd., Dr G.V. Subramanium, also gave a brief introduction regarding the activities of their company.
The online meeting ended with a vote of thanks given by the senior-most scientist of the institute, Dr P.K. Khanna.